SARAH BAILEY: Open Payments
NPI 1245247808 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 6 payments from 4 companies in 2025. Trend: 2023 $325 · 2024 $287 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $42 |
| ABBVIE INC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Biogen, Inc. | 1 | $18 |
Products named: NEXPLANON, QULIPTA, Veozah, ZURZUVAE.
Industry payments across IN — which companies pay providers there.
